Skip to content

Efficacy of Collagen Matrix Implant in Pterygium Surgery

Efficacy of Collagen Matrix Implant in Pterygium Surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-14005402
Enrollment
Unknown
Registered
2014-10-29
Start date
2014-11-12
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pterygium

Interventions

Two groups:A standard surgical technique versus Ologen device
(to be continued):Ologen device has a rectangular shape with 95% porous space. The pore size ranges from 10 to 300 µm. It comes in dry form consisting of over 90% lyophilized atelo-collagen and less t
(to be continued):After implantation, the device dissolves slowly and is completely degraded within 90-180 days. The ologen is sterilized using gamma radiation.

Sponsors

Department of Ophthalmology and Visual Sciences, the Chinese University of Hon Kong
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Age 18 years or over; 2) Subject who diagnosed with pterygium requiring excision; 3) Subject able and willing to cooperate with investigation plan; 4) Subject able and willing to complete postoperative follow-up requirements; 5) Subject willing to sign informed consent form.

Exclusion criteria

Exclusion criteria: 1) Known allergic reaction to collagen; 2) Co-existing ocular infection or inflammation; 3) Pregnant or breast-feeding women.

Design outcomes

Primary

MeasureTime frame
Pterygium recurrence rate at the end of 12 months postoperatively;

Secondary

MeasureTime frame
Complications associated with the surgery;Best-corrected visual acuity at the end of 12 months;

Countries

China

Contacts

Public ContactDr. Jhanji, Vishal

The Chinese University of Hong Kong

vishaljhanji@cuhk.edu.hk+852 39435807

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026